Clinical trials: Asthma Exacerbation
Asthma
Creation of Home-based Asthma Real-World Measures With Mobile Health Study
Four novel biologic therapies (benralizumab, dupilumab, mepolizumab, reslizumab) have been recently approved for moderate-to-severe, eosinophilic or oral steroid-dependent asthma.
- Trial name
- CHARM (NCT04462224)
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- National Jewish Health
Asthma
Thyroid Hormones Treatment in Asthma Exacerbation
This study will explore whether supplementation with thyroid hormones in the set-up of asthma exacerbation could improve the clinical outcomes.
- Trial name
- THINAS (NCT02086799)
- Testing
- IV thyroxin
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- Rambam Health Care Campus
Severe Asthma
Severe Asthma Exacerbations and Mepolizumab Treatment
This is a hypothesis-generating project to investigate a) infective etiology and b) inflammatory profile of the exacerbations of asthma in severe asthmatic patients treated with the humanized monoclonal antibody against…
- Trial name
- ESAM-BIO (NCT04914078)
- Testing
- Mepolizumab 100 MG
- Where
- Italy
- Volunteers
- 70 people
- Sponsor
- Università degli Studi di Ferrara